Skip to main content
OpenTrials
Completed

NCT Number: NCT07570602

VisionApp - Refraction and Presbyopia

Recent Android mobile device technology is available which allows user-measured refractive error and reading add power. This technology could be quite useful to the clinical and research community. The current study aims to evaluate the accuracy, repeatability, and reproducibility of one such technology by VisionApp, specifically with regard to refraction and presbyopia.

VisionApp is an app which runs on a smartphone or other device which uses the distance between the user's face and the phone to determine refractive error, while the user looks at different targets (lines, letters, words, etc).

Completed

Looking for future studies?

Notify Me

Key information

Age range

40 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Clinical Optics Research Lab

Bloomington, Indiana, 47405, United States

About this study

Subjects will be enrolled at the Clinical Optics Research Lab at Indiana University and complete a single study visit.

At the study visit, demographic and health/ocular history may be collected by oral history and standard clinical testing including refraction (check of glasses prescription), auto-refraction or aberrometry may be performed. Visual acuity and room lighting checks may also be measured using standard clinical techniques.

For the experimental portion of the study visit, the subject will look at a phone running the VisionApp program set at a particular distance (calibration) and then be instructed to move further from, or closer to the phone, until a given target (letter, lines, patterns, etc) are more or less clear. Each test may be repeated until at least 10 good data points are collected. This may be done on the right eye, left eye, or both eyes.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • at least 40 years of age and currently wears a near add correction
  • has a refractive error between Plano and -5.00 D of sphere and cylinder components combined.
  • has best corrected visual acuity of at least 20/20 in each eye
  • is not amblyopic or have any diagnosed ocular disease
  • is willing and able to follow instructions and maintain the appointment schedule

Exclusion criteria

  • has any systemic disease affecting ocular health and visual acuity
  • is currently using any systemic or topical medications that could affect ocular health and visual acuity
  • is participating in another eye related research study

Treatment and study plan

VisionApp

Device

VisionApp is an app which runs on a smartphone or other device which uses the distance between the user's face and the phone to determine refractive error, while the user looks at different targets (lines, letters, words, etc).

Primary outcomes

  1. Spherical Equivalent Refractive Error

    Time frame: Day 1

    Spherical equivalent refractive error in diopters will be compared between Myopia Check and traditional refraction.

  2. Near Presbyopic Add

    Time frame: Day 1

    Presbyopic near point in diopters as measured by the VisionApp technique and composite standard clinical measurements.

Sponsors and collaborators

Lead sponsor

Indiana University

Other

Registry information

Official study title

Assessment of the Accuracy and Repeatability of the VisionApp - Refraction and Presbyopia Measurement Protocol

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
May 6, 2026
Registry last updated
Jun 11, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.